Borealis is a three-storey multi-platform biotech manufacturing facility capable of manufacturing mAbs, mRNA, Viral, Plasmid and Cell & Gene Therapy products. The facility will be designed, constructed and qualified for GMP manufacturing operations by the end of 2024.
Asgard became an integrated design partner under a PCSA. This allowed us to develop a cloned project deign in parallel, Borealis (Billingham) & Flag Ship (College station, Texas). Taking both projects through 30%, 60% design review into detail design and final delivery.